ArticleCancers2022

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients.

Ji Hoon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.